Literature DB >> 27169753

Laboratory assessment of vitamin B12 status.

Dominic J Harrington1,2.   

Abstract

The detection and correction of vitamin B12 (B12) deficiency prevents megaloblastic anaemia and potentially irreversible neuropathy and neuropsychiatric changes. B12 status is commonly estimated using the abundance of the vitamin in serum, with ∼148 pmol/L (200 ng/L) typically set as the threshold for diagnosing deficiency. Serum B12 assays measure the sum of haptocorrin-bound and transcobalamin-bound (known as holotranscobalamin) B12 It is only holotranscobalamin that is taken up by cells to meet metabolic demand. Although receiver operator characteristic curves show holotranscobalamin measurement to be a moderately more reliable marker of B12 status than serum B12, both assays have an indeterminate range. Biochemical evidence of metabolic abnormalities consistent with B12 insufficiency is frequently detected despite an apparently sufficient abundance of the vitamin. Laboratory B12 status markers that reflect cellular utilisation rather than abundance are available. Two forms of B12 act as coenzymes for two different reactions. Methionine synthase requires methylcobalamin for the remethylation of methionine from homocysteine. A homocysteine concentration >20 µmol/L may suggest B12 deficiency in folate-replete patients. In the second B12-dependent reaction, methylmalonyl-CoA mutase uses adenosylcobalamin to convert methylmalonyl-CoA to succinyl-CoA. In B12 deficiency excess methylmalonyl-CoA is hydrolysed to methylmalonic acid. A serum concentration >280 nmol/L may suggest suboptimal status in young patients with normal renal function. No single laboratory marker is suitable for the assessment of B12 status in all patients. Sequential assay selection algorithms or the combination of multiple markers into a single diagnostic indicator are both approaches that can be used to mitigate inherent limitations of each marker when used independently. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  B12; COBALAMIN; DIAGNOSIS; LABORATORY TESTS

Mesh:

Substances:

Year:  2016        PMID: 27169753     DOI: 10.1136/jclinpath-2015-203502

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  Measurement of methylated metabolites using Liquid Chromatography-Mass Spectrometry and its biological application.

Authors:  Chandrashekar R Ambati; Venkatrao Vantaku; Sri Ramya Donepudi; Chandra Sekhar Amara; Shiva Shankar Ravi; Akhil Mandalapu; Maharajni Perla; Vasanta Putluri; Arun Sreekumar; Nagireddy Putluri
Journal:  Anal Methods       Date:  2018-11-15       Impact factor: 2.896

2.  Assessing Diagnostic Accuracy of Serum Holotranscobalamin (Active-B12) in Comparison with Other Markers of Vitamin B12 Deficiency.

Authors:  Joseph Dian Bondu; Arun Jose Nellickal; L Jeyaseelan; F S Geethanjali
Journal:  Indian J Clin Biochem       Date:  2019-06-12

Review 3.  Association of TCN2 rs1801198 c.776G>C polymorphism with markers of one-carbon metabolism and related diseases: a systematic review and meta-analysis of genetic association studies.

Authors:  Abderrahim Oussalah; Julien Levy; Pierre Filhine-Trésarrieu; Fares Namour; Jean-Louis Guéant
Journal:  Am J Clin Nutr       Date:  2017-08-16       Impact factor: 7.045

4.  Non-Linear Association between Folate/Vitamin B12 Status and Cognitive Function in Older Adults.

Authors:  Zhe Ding; Lihui Luo; Shaohui Guo; Qing Shen; Yueying Zheng; Shengmei Zhu
Journal:  Nutrients       Date:  2022-06-13       Impact factor: 6.706

5.  Diagnostic value of oral "beefy red" patch combined with fingertip blood mean corpuscular volume in vitamin B12 deficiency.

Authors:  Xiaoheng Xu; Yang Liu; Xiaoqin Xiong; Yanmei Yao; Huiting Hu; Xiao Jiang; Wenxia Meng
Journal:  BMC Oral Health       Date:  2022-07-05       Impact factor: 3.747

Review 6.  Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part II. Insights from two MS cases.

Authors:  Susan J van Rensburg; Coenraad Hattingh; Clint Johannes; Kelebogile E Moremi; Armand V Peeters; Carel J van Heerden; Rajiv T Erasmus; Annalise E Zemlin; Merlisa C Kemp; Mariaan Jaftha; Aye Aye Khine; Felix C V Potocnik; Lindiwe Whati; Penelope Engel-Hills; Ronald van Toorn; Maritha J Kotze
Journal:  Metab Brain Dis       Date:  2021-03-12       Impact factor: 3.584

7.  Neurologic symptoms as the only manifestation of B12 deficiency in a young patient with normal hematocrit, MCV, peripheral blood smear and homocysteine levels.

Authors:  Panagiota Voukelatou; Ioannis Vrettos; Andreas Kalliakmanis
Journal:  Oxf Med Case Reports       Date:  2016-12-01

Review 8.  Monitoring of long-term parenteral nutrition in children with intestinal failure.

Authors:  Boutaina Zemrani; Julie E Bines
Journal:  JGH Open       Date:  2019-01-08

Review 9.  The Many Faces of Cobalamin (Vitamin B12) Deficiency.

Authors:  Bruce H R Wolffenbuttel; Hanneke J C M Wouters; M Rebecca Heiner-Fokkema; Melanie M van der Klauw
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2019-05-27

10.  Serum homocysteine concentration in dogs with immunosuppressant-responsive enteropathy.

Authors:  Elena Benvenuti; Alessio Pierini; Eleonora Gori; Enrico Bottero; Marco Pietra; Ilaria Lippi; Valentina Meucci; Veronica Marchetti
Journal:  J Vet Sci       Date:  2020-07       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.